Literature DB >> 33424834

Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency.

Johannes A Bezuidenhout1, Chantelle Venter1, Timothy J Roberts1,2,3, Gareth Tarr4, Douglas B Kell1,2,5, Etheresia Pretorius1.   

Abstract

Aims: The risk of cardiovascular events in patients with Rheumatoid Arthritis (RA) is disproportionately heightened as a result of systemic inflammation. The relative effect of autoimmune-associated citrullination on the structure and thrombotic potential of fibrin(ogen) remains unknown. We therefore compared indices of vascular function, inflammation, coagulation and fibrin clot composition in RA patients with healthy controls and evaluated parameter association with disease presence.
Methods: Blood samples were collected from 30 RA patients and 30 age- and gender-matched healthy volunteers. Levels of serum amyloid A (SAA), c-reactive protein (CRP), soluble intercellular adhesion molecule 1 (sICAM-1) and soluble vascular cell adhesion molecule 1 (sVCAM-1) was measured using a sandwich immunoassay. Whole blood coagulation was assessed using Thromboelastography (TEG®). Fibrin clot networks and fiber structure was investigated using Scanning Electron Microscopy. The detection and quantification of citrullination in formed fibrin clots was performed using a fluorescently labeled Citrulline monoclonal antibody with Fluorescence Wide Field Microscopy.
Results: Concentrations of SAA, CRP and ICAM-1 were significantly elevated in RA patients compared to controls. TEG parameters relating to coagulation initiation, rate of fibrin cross-linking, and time to reach maximum thrombus generation were attenuated in RA patients. Microscopic analysis revealed denser networks of thicker fibrin fibers in RA patients compared to controls and multiple citrullinated regions within fibrin clot structures in RA patients were present.
Conclusion: Our findings provide novel evidence for the citrullination of fibrin within vasculature is more prominent in RA plasma compared to control plasma and plasma is more accessible than synovial fluid. Citrullinated fibrinogen could play a role as a determinant of thrombotic risk in RA patients.
Copyright © 2020 Bezuidenhout, Venter, Roberts, Tarr, Kell and Pretorius.

Entities:  

Keywords:  cardiovascular risk; citrullination; coagulation; fibrinogen; rheumatoid arthritis

Mesh:

Substances:

Year:  2020        PMID: 33424834      PMCID: PMC7793985          DOI: 10.3389/fimmu.2020.577523

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  54 in total

1.  Alterations of the thrombin generation profile in rheumatoid arthritis.

Authors:  Anita Kern; Attila Balog; Sonja Dulic; Eszter Barabás; Mária Kiszelák; Barna Vásárhelyi
Journal:  J Thromb Thrombolysis       Date:  2016-04       Impact factor: 2.300

Review 2.  Adverse cardiovascular effects of antirheumatic drugs: implications for clinical practice and research.

Authors:  Armen Yuri Gasparyan; Lilit Ayvazyan; Giuseppe Cocco; George D Kitas
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

3.  Thrombin generation in rheumatoid arthritis: dependence on plasma factor composition.

Authors:  Anetta Undas; Matthew Gissel; Beata Kwasny-Krochin; Piotr Gluszko; Kenneth G Mann; Kathleen E Brummel-Ziedins
Journal:  Thromb Haemost       Date:  2010-06-30       Impact factor: 5.249

Review 4.  Cross Talk Pathways Between Coagulation and Inflammation.

Authors:  Jonathan H Foley; Edward M Conway
Journal:  Circ Res       Date:  2016-04-29       Impact factor: 17.367

5.  Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis.

Authors:  Terence Rooney; Rebecca Scherzer; Judy K Shigenaga; Jonathan Graf; John B Imboden; Carl Grunfeld
Journal:  Rheumatology (Oxford)       Date:  2011-03-26       Impact factor: 7.580

Review 6.  Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis.

Authors:  Berthold Hoppe; Thomas Dörner
Journal:  Nat Rev Rheumatol       Date:  2012-11-13       Impact factor: 20.543

7.  Blood clot parameters: Thromboelastography and scanning electron microscopy in research and clinical practice.

Authors:  Etheresia Pretorius; Albe C Swanepoel; Sulette DeVilliers; Janette Bester
Journal:  Thromb Res       Date:  2017-04-11       Impact factor: 3.944

8.  High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.

Authors:  Nathalie E Blachère; Salina Parveen; Mayu O Frank; Brian D Dill; Henrik Molina; Dana E Orange
Journal:  Arthritis Rheumatol       Date:  2017-05       Impact factor: 10.995

9.  Physical determinants of fibrinolysis in single fibrin fibers.

Authors:  Igal Bucay; E Tim O'Brien; Steven D Wulfe; Richard Superfine; Alisa S Wolberg; Michael R Falvo; Nathan E Hudson
Journal:  PLoS One       Date:  2015-02-25       Impact factor: 3.240

10.  Circulating immune complexes contain citrullinated fibrinogen in rheumatoid arthritis.

Authors:  Xiaoyan Zhao; Nwora Lance Okeke; Orr Sharpe; Franak M Batliwalla; Annette T Lee; Peggy P Ho; Beren H Tomooka; Peter K Gregersen; William H Robinson
Journal:  Arthritis Res Ther       Date:  2008-08-18       Impact factor: 5.156

View more
  3 in total

Review 1.  A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications.

Authors:  Douglas B Kell; Gert Jacobus Laubscher; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-02-17       Impact factor: 3.857

Review 2.  The potential role of ischaemia-reperfusion injury in chronic, relapsing diseases such as rheumatoid arthritis, Long COVID, and ME/CFS: evidence, mechanisms, and therapeutic implications.

Authors:  Douglas B Kell; Etheresia Pretorius
Journal:  Biochem J       Date:  2022-08-31       Impact factor: 3.766

Review 3.  Pathogenic implications, incidence, and outcomes of COVID-19 in autoimmune inflammatory joint diseases and autoinflammatory disorders.

Authors:  Piero Ruscitti; Alessandro Conforti; Marco Tasso; Luisa Costa; Francesco Caso; Paola Cipriani; Roberto Giacomelli
Journal:  Adv Rheumatol       Date:  2021-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.